Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central nervous system, conolidine modulates alternate molecular targets. A Science Advancements analyze found that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://edenv814kga4.nizarblog.com/profile